| /report/000138550823000057-gorman-brian-2023-03-02 |
OPIANT PHARMACEUTICALS, INC. |
02 Mar 2023 |
6 |
-$679,800 |
4 |
General Counsel |
03 Mar 2023, 08:03 |
| /report/000138550823000032-gorman-brian-2023-01-27 |
OPIANT PHARMACEUTICALS, INC. |
27 Jan 2023 |
1 |
-$8,995 |
4 |
General Counsel |
31 Jan 2023, 15:20 |
| /report/000138550823000009-gorman-brian-2023-01-05 |
OPIANT PHARMACEUTICALS, INC. |
05 Jan 2023 |
1 |
-$26,523 |
4 |
General Counsel |
05 Jan 2023, 15:59 |
| /report/000138550822000110-gorman-brian-2022-07-14 |
OPIANT PHARMACEUTICALS, INC. |
14 Jul 2022 |
1 |
-$7,712 |
4 |
General Counsel |
15 Jul 2022, 16:04 |
| /report/000138550822000100-gorman-brian-2022-06-27 |
OPIANT PHARMACEUTICALS, INC. |
27 Jun 2022 |
1 |
$0 |
4 |
General Counsel |
29 Jun 2022, 16:02 |
| /report/000138550822000066-gorman-brian-2022-06-02 |
OPIANT PHARMACEUTICALS, INC. |
02 Jun 2022 |
1 |
-$15,521 |
4 |
General Counsel |
06 Jun 2022, 16:07 |
| /report/000138550822000010-gorman-brian-2022-01-04 |
OPIANT PHARMACEUTICALS, INC. |
04 Jan 2022 |
1 |
$0 |
4 |
General Counsel |
05 Jan 2022, 15:18 |
| /report/000138550821000128-gorman-brian-2021-09-14 |
OPIANT PHARMACEUTICALS, INC. |
14 Sep 2021 |
2 |
+$24,980 |
4 |
General Counsel |
14 Sep 2021, 16:01 |